AI-generated summary
The authors of this position paper reviewed published studies on combining photobiomodulation with stem cells across molecular, cellular and tissue levels, aiming to suggest consensus treatment parameters. They report benefits in cell proliferation, differentiation, tissue regeneration and wound healing in many studies, but describe a considerable lack of clinical studies and wide variation in light parameters. The authors note that the main wavelengths used were in the range of 630 to 660 nm and 800 to 890 nm.
- Who or what was studied
- unclear
- Wavelengths
- 630, 660, 800, 890 nm
- Limits stated in the abstract
- The abstract states there is a considerable lack of clinical studies and that study designs and light parameters varied widely, with recommendations based partly on expert experience.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630-660 nm, 800-890 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Wound healing, Angiogenesis, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.